Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Safety of multiple doses of STK-001. After: Measure: Safety of multiple doses of zorevunersen.
Study sponsor: Stoke Therapeutics, Inc · STOK
Primary completion is the date data collection ends for the main study measures, not when results are published.
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Before: Measure: Safety of multiple doses of STK-001. After: Measure: Safety of multiple doses of zorevunersen.